1. Home
  2. CDZI vs VRXA Comparison

CDZI vs VRXA Comparison

Compare CDZI & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CDZI

CADIZ Inc.

HOLD

Current Price

$3.01

Market Cap

342.2M

Sector

Utilities

ML Signal

HOLD

Logo Veraxa Biotech AG Ordinary Shares

VRXA

Veraxa Biotech AG Ordinary Shares

N/A

Current Price

$1.76

Market Cap

390.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CDZI
VRXA
Founded
1983
N/A
Country
United States
Switzerland
Employees
31
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
342.2M
390.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CDZI
VRXA
Price
$3.01
$1.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3M
951.5K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.97
N/A
Revenue Next Year
$102.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.87
$1.70
52 Week High
$6.96
$4.50

Technical Indicators

Market Signals
Indicator
CDZI
VRXA
Relative Strength Index (RSI) 35.92 29.98
Support Level N/A $1.74
Resistance Level $5.08 $2.29
Average True Range (ATR) 0.24 0.20
MACD -0.03 0.04
Stochastic Oscillator 20.41 13.46

Price Performance

Historical Comparison
CDZI
VRXA

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, generating maximum revenue engaged in providing water filtration solutions for impaired or contaminated groundwater sources.

About VRXA Veraxa Biotech AG Ordinary Shares

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Share on Social Networks: